Fang L - Search Results

1

Fang L, Lonsdorf AS, Hwang ST. Fang L, et al. J Invest Dermatol. 2008 Nov;128(11):2596-2605. doi: 10.1038/jid.2008.101. J Invest Dermatol. 2008. PMID: 18927541 Free PMC article. Review.

2

Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells.

Huang V, Lonsdorf AS, Fang L, Kakinuma T, Lee VC, Cha E, Zhang H, Nagao K, Zaleska M, Olszewski WL, Hwang ST. Huang V, et al. Among authors: fang l. J Immunol. 2008 May 15;180(10):6462-6. doi: 10.4049/jimmunol.180.10.6462. J Immunol. 2008. PMID: 18453562 Free PMC article.

3

CCR7 regulates B16 murine melanoma cell tumorigenesis in skin.

Fang L, Lee VC, Cha E, Zhang H, Hwang ST. Fang L, et al. J Leukoc Biol. 2008 Oct;84(4):965-72. doi: 10.1189/jlb.1107776. J Leukoc Biol. 2008. PMID: 18519742 Free PMC article.

4

Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes.

Sugaya M, Fang L, Cardones AR, Kakinuma T, Jaber SH, Blauvelt A, Hwang ST. Sugaya M, et al. Among authors: fang l. J Immunol. 2006 Dec 1;177(11):7665-72. doi: 10.4049/jimmunol.177.11.7665. J Immunol. 2006. PMID: 17114436

5

CCR7-expressing B16 melanoma cells downregulate interferon-γ-mediated inflammation and increase lymphangiogenesis in the tumor microenvironment.

Takekoshi T, Fang L, Paragh G, Hwang ST. Takekoshi T, et al. Among authors: fang l. Oncogenesis. 2012 May 7;1(5):e9. doi: 10.1038/oncsis.2012.9. Oncogenesis. 2012. PMID: 23552640 Free PMC article.

6

Genetic immunization with LYVE-1 cDNA yields function-blocking antibodies against native protein.

Cardones AR, Leitner WW, Fang L, Murakami T, Kapoor V, Udey MC, Hwang ST. Cardones AR, et al. Among authors: fang l. Microvasc Res. 2006 Jan;71(1):32-9. doi: 10.1016/j.mvr.2005.09.002. Epub 2005 Oct 28. Microvasc Res. 2006. PMID: 16257423

7

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.

Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K. Liu YN, et al. Among authors: fang l. Oncogene. 2013 Jan 17;32(3):296-306. doi: 10.1038/onc.2012.58. Epub 2012 Feb 27. Oncogene. 2013. PMID: 22370643 Free PMC article.

8

High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.

Jansson KH, Tucker JB, Stahl LE, Simmons JK, Fuller C, Beshiri ML, Agarwal S, Fang L, Hynes PG, Alilin AN, Lake R, Abbey YC, Cawley J, Tice CM, Yin J, McKnight C, Klummp-Thomas C, Zhang X, Guha R, Hoover S, Simpson RM, Nguyen HM, Corey E, Thomas CJ, Proia DA, Kelly K. Jansson KH, et al. Among authors: fang l. Sci Rep. 2018 Nov 22;8(1):17239. doi: 10.1038/s41598-018-35417-0. Sci Rep. 2018. PMID: 30467317 Free PMC article.

9

Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.

Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K. Liu YN, et al. Among authors: fang l. Mol Cell Biol. 2012 Mar;32(5):941-53. doi: 10.1128/MCB.06306-11. Epub 2011 Dec 27. Mol Cell Biol. 2012. PMID: 22203039 Free PMC article.

10

AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis.

Yin J, Liu YN, Tillman H, Barrett B, Hewitt S, Ylaya K, Fang L, Lake R, Corey E, Morrissey C, Vessella R, Kelly K. Yin J, et al. Among authors: fang l. Cancer Res. 2014 Aug 15;74(16):4306-17. doi: 10.1158/0008-5472.CAN-13-3233. Epub 2014 Jun 26. Cancer Res. 2014. PMID: 24970477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,341 results

Search Page